Go Unlimited with Magzter GOLD
Get unlimited access to 10,000+ magazines, newspapers and Premium stories for just
Try GOLD - Free
True North sells 20% of Niva Bupa for ₹2,700 cr
Mint Mumbai
|September 30, 2023
Private equity fund True North on Friday said it sold a 20% stake in general insurer Niva Bupa to its partner Bupa of UK for around ₹2,700 crore, making the latter the biggest shareholder in the 15-year-old company
The UK-based international healthcare and insurance company, which tied up with India's Max group to launch Max Bupa in 2008, will hold around 63% of the company once the transaction is concluded. True North, through its special purpose vehicle (SPV) Fettle Tone, will hold around 28%.
Niva Bupa also plans to raise around 1,100 crore in primary capital that will value it at 12,600 crore once the fundraising is concluded, said Divya Sehgal, partner at True North partner. The company is also looking for an initial public offering in the next 12-15 months.
This story is from the September 30, 2023 edition of Mint Mumbai.
Subscribe to Magzter GOLD to access thousands of curated premium stories, and 10,000+ magazines and newspapers.
Already a subscriber? Sign In
MORE STORIES FROM Mint Mumbai
Mint Mumbai
Europe bets on $25 bn space budget amid defence hike
Europe’s equivalent of NASA is seeking €22 billion ($25.
1 min
November 27, 2025
Mint Mumbai
China’s ‘McNuggetization’: It’s beneficial for the environment
A wide-scope dietary shift in China is doing the planet a good turn
3 mins
November 27, 2025
Mint Mumbai
Flexi-cap funds in focus as smids falter
A silent pivot
3 mins
November 27, 2025
Mint Mumbai
Labour codes: Focus on empathy and not just efficiency
The consolidation of 29 archaic labour laws into four comprehensive new codes—on wages, social security, industrial relations and occupational safety—is among the most significant structural reforms undertaken by India in the post-liberalization era.
3 mins
November 27, 2025
Mint Mumbai
These firms will sell shovels during semaglutide gold rush
Weight-loss drug semaglutide, also used to treat type-2 diabetes, will face its next big turning point in early 2026, when patents held by Novo Nordisk expire in India.
2 mins
November 27, 2025
Mint Mumbai
HC to hear Apple's plea on fine in Dec
Apple is challenging the new penalty math formula in India's competition law.
1 min
November 27, 2025
Mint Mumbai
Climate crisis: Innovation works, compression doesn't
After weeks of hot air, the UN’s CoP summit limped to an end in Brazil's Amazonian hub of Belém over the weekend, with a ‘deal’ that delivers nothing measurable for the climate, while wasting political capital and much effort on pledges.
3 mins
November 27, 2025
Mint Mumbai
MO Alternates launches its maiden private credit fund
The %3,000 crore fund has drawn capital from family offices, ultra-HNIs and institutions
3 mins
November 27, 2025
Mint Mumbai
Kharif grain production likely to rise to 173 mt
India's kharif foodgrain output is expected to rise to 173.
1 min
November 27, 2025
Mint Mumbai
IL&FS group repays ₹48,463 cr loan
Debt-ridden IL&FS group has repaid ₹48,463 crore to its creditors as of September 2025, out of the total ₹61,000 crore debt resolution target, as per the latest status report filed before insolvency appellate tribunal NCLAT.
1 min
November 27, 2025
Translate
Change font size